Area of research
Hematology · Immunology
Research interest
Research focused on ADAMTS13 and Von Willebrand factor, with related work in Von Willebrand disease, Osteosarcoma, RNA splicing. Notable publications include 'von Willebrand factor rescued by miR-24 inhibition facilitates the proliferation and migration of osteosarcoma cells in vitro', 'Novel mutations in ADAMTS13 CUB domains cause abnormal pre‐mRNA splicing and defective secretion of ADAMTS13', and 'Nonsense‐mediated mRNA decay efficiency influences bleeding severity in ITGA2B c. 2659C > T (p. Q887X ) knock‐in mice'.
Nonsense‐mediated mRNA decay efficiency influences bleeding severity in <i>ITGA2B</i> c. <scp>2659C</scp> > T (p. <scp>Q887X</scp> ) knock‐in mice
Novel mutations in ADAMTS13 CUB domains cause abnormal pre‐mRNA splicing and defective secretion of ADAMTS13
von Willebrand factor rescued by <i>miR-24</i> inhibition facilitates the proliferation and migration of osteosarcoma cells <i>in vitro</i>
The co-influence of VWD type 2B/2M mutations in the A1 domain and platelet GPIbα on the rate of cleavage to VWF by ADAMTS13
The Co-Influence of VWD Type 2B and Type 2M Mutations and Platelet GPIbα On the Susceptibility of VWF to ADAMTS13 Under Shear Stress
The value of anti-von Willebrand factor antibody in the mechanism of idiopathic thrombotic thrombocytopenic purpura